SCHEMBL16600949

SCHEMBL16600949

Oc1ccc(C(O)CCC2CCC(c3ccccc3)C2)cc1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 5/20 0.55
GRIN1 Q05586 2/20 0.47
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
ADRA1D P25100 1/20 0.47
ADRA1A P35348 1/20 0.47
ADRA1B P35368 1/20 0.47
GRIN2A Q12879 1/20 0.47
GRIN2C Q14957 1/20 0.47
GRIN3A Q8TCU5 1/20 0.47
SLC18A3 Q16572 4/20 0.44
ESR2 Q92731 2/20 0.43
SIGMAR1 Q99720 2/20 0.43
ESR1 P03372 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16600897 0.77 IDO1 (0.53) GRIN2BSLC18A3SIGMAR1
SCHEMBL17073447 0.76 RIPK1 (0.53) GRIN2BGRIN1GRIN2DGRIN3BADRA1D
SCHEMBL16601319 0.71 GRIN2B (1.00) GRIN2BGRIN1
SCHEMBL16608307 0.71 GRIN2B (1.00) GRIN2BGRIN1
SCHEMBL5689684 0.69 GRIN2B (0.45) GRIN2BGRIN1GRIN2DGRIN3BADRA1D
SCHEMBL5689681 0.69 GRIN2B (0.45) GRIN2BGRIN1GRIN2DGRIN3BADRA1D
SCHEMBL8029809 0.69 SLC18A3 (0.56) SLC18A3ESR2SIGMAR1ESR1CYP3A4
SCHEMBL26999319 0.69 SLC18A3 (0.56) SLC18A3ESR2SIGMAR1ESR1CYP3A4
SCHEMBL8029813 0.69 SLC18A3 (0.56) SLC18A3ESR2SIGMAR1ESR1CYP3A4
SCHEMBL766285 0.69 AKR1C3 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3036221-A1 SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B Luc Therapeutics, Inc. (US) 2016-06-29 EP disclosed
WO-2015048507-A1 SELECTIVE OCTAHYDRO-CYCLOPENTA[C] PYRROLE NEGATIVE MODULATORS OF NR2B MNEMOSYNE PHARMACEUTICALS, INC. (US) 2015-04-02 WO disclosed